Clinical usefulness of assays for complexed prostate-specific antigen
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 29 (1) , 193-203
- https://doi.org/10.1016/s0094-0143(02)00004-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mLUrology, 2000
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- EXAMINATION OF THE 3 MOLECULAR FORMS OF SERUM PROSTATE SPECIFIC ANTIGEN FOR DISTINGUISHING NEGATIVE FROM POSITIVE BIOPSY: RELATIONSHIP TO TRANSITION ZONE VOLUMEJournal of Urology, 2000
- The stability of free and bound prostate‐specific antigenBJU International, 1999
- LONG-TERM STABILITY OF COMPLEX PROSTATE SPECIFIC ANTIGEN (PSA) IN FROZEN SERUMJournal of Urology, 1999
- A comparison of three free and total PSA assaysProstate Cancer and Prostatic Diseases, 1998
- COMPARISON OF 3 INVESTIGATIONAL ASSAYS FOR THE FREE FORM OF PROSTATE SPECIFIC ANTIGENJournal of Urology, 1998
- In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samplesUrology, 1996
- Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditionsUrology, 1996
- Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994Urology, 1995